Austrian breast cancer screening a success:
This article was originally published in Clinica
The steady fall in the number of women dying from breast cancer in Austria over the past 10 years is a result of effective early detection and improved therapy, says the Vienna regional sickness fund (WGKK). Vienna introduced screening of women between the ages of 50-70 under the auspices of the WGKK, the Viennese doctors' chamber and the Vienna council, in 2001. The screening added to earlier measures that saw the three-year survival rate, which was some 15% in the 1970s, reach 61% by the end of the 1990's, it claims. The five-year rate has also risen from 10-40% over the same period. 18 Viennese women contract breast cancer and eight die from the disease per week, on average.
You may also be interested in...
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.